The Conduit Artery Functional Endpoint (CAFE) study in ASCOT.
Williams
B
B
Cardiovascular Research Institute, Faculty of Medicine and Biological Sciences, University of Leicester, UK. bw17@le.ac.uk
O'Rourke
M
M
D000924:Anticholesteremic Agents / Q000627:therapeutic use*; D000959:Antihypertensive Agents / Q000627:therapeutic use*; D001794:Blood Pressure / Q000187:drug effects; D001795:Blood Pressure Determination; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000627:therapeutic use; D006937:Hypercholesterolemia / Q000188:drug therapy* / Q000503:physiopathology; D006973:Hypertension / Q000188:drug therapy* / Q000503:physiopathology; D011446:Prospective Studies; D011674:Pulse; D012107:Research Design
D000924:Anticholesteremic Agents; D000959:Antihypertensive Agents; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors